Type
. The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes. Immunology. 1987;61(2):125-9.
Type
. Surgical management in ocular leprosy. Indian journal of ophthalmology. 1987;35(3):153-7.
Type
. [Treatment of patients with temporomandibular joint pathology developing in lepromatous leprosy]. Stomatologiia. 1987;66(3):41-3.
Type
. [Assessment and treatment of the dry eye in Hansen's disease]. Revista brasileira de enfermagem. 1987;40(2-3):118-22.
Type
. Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice. Antimicrobial agents and chemotherapy. 1987;31(4):671-2.
Type
. [Skin diseases in Sierra Leone]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1987;38(3):146-54.
Type
. Hypercalcaemia and elevated 1,25-dihydroxy-vitamin D3 levels in a patient with multibacillary leprosy and a type I leprosy reaction. The New Zealand medical journal. 1987;100(817):86.
Type
. Idiotypic markers of polyclonal B cell activation. Public idiotypes shared by monoclonal antibodies derived from patients with systemic lupus erythematosus or leprosy. The Journal of clinical investigation. 1987;79(2):572-81.
Type
. [Immunological analysis in leprosy]. Igaku kenkyu. Acta medica. 1987;57(1):1-9.
Type
. Oral lesions in lepromatous leprosy. Journal of oral medicine. 1987;42(1):4-6.